Serum prostate-specific antigen and chromogranin A levels steadily decreased over a 12-mo follow-up period, at which time the patient is alive without disease progression and with a complete objective and symptomatic response.
COMPLETE RESPONSE TO THE COMBINATION THERAPY WITH ANDROGEN BLOCKADE AND SOMATOSTATIN ANALOGUE IN A PATIENT WITH ADVANCED PROSTATE CANCER: MAGNETIC RESONANCE IMAGING WITH 1H-SPECTROSCOPY: Part 2 / Sciarra, Alessandro; Panebianco, Valeria; Ciccariello, Mauro; Salciccia, Stefano; Gentilucci, Alessandro; Lisi, Danilo; Passariello, Roberto; Gentile, Vincenzo; DI SILVERIO, Franco. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - STAMPA. - 53:4(2008), pp. 849-850. [10.1016/j.eururo.2007.02.009]
COMPLETE RESPONSE TO THE COMBINATION THERAPY WITH ANDROGEN BLOCKADE AND SOMATOSTATIN ANALOGUE IN A PATIENT WITH ADVANCED PROSTATE CANCER: MAGNETIC RESONANCE IMAGING WITH 1H-SPECTROSCOPY: Part 2
SCIARRA, Alessandro;PANEBIANCO, VALERIA;CICCARIELLO, Mauro;SALCICCIA, STEFANO;GENTILUCCI, ALESSANDRO;LISI, DANILO;PASSARIELLO, Roberto;GENTILE, Vincenzo;DI SILVERIO, Franco
2008
Abstract
Serum prostate-specific antigen and chromogranin A levels steadily decreased over a 12-mo follow-up period, at which time the patient is alive without disease progression and with a complete objective and symptomatic response.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
